Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Palliative Care
Published in: BMC Palliative Care 1/2018

Open Access 01-12-2018 | Research article

Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services

Authors: Stephanie Stiel, Mareike Nurnus, Christoph Ostgathe, Carsten Klein

Published in: BMC Palliative Care | Issue 1/2018

Login to get access

Abstract

Background

Clinical practice of Palliative Sedation (PS) varies between institutions worldwide and sometimes includes problematic practices. Little available research points at different definitions and frameworks which may contribute to uncertainty of healthcare professionals in the application of PS. This analysis investigates what demographic factors and characteristics of treatment practices differ between institutions with high versus low sedation rates estimates in Palliative and Hospice Care in Germany.

Methods

Data sets from 221 organisations from a prior online survey were separated into two sub-groups divided by their estimated sedation rate A) lower/equal to 16% (n = 187; 90.8%) and B) higher than 16% (n = 19; 9.2%) for secondary analysis. Demographic factors and characteristics of PS treatment practices between the two groups were compared using T-Tests and Chi2/ Fisher Exact Tests and considered significant (*) at two-sided p < .05.

Results

Organisations in group B report that they discuss PS for a higher proportion of patients (38.5%/10.2%, p < 0.000**), rate agitation more often as an indications for PS (78.9%/ 53.5%, p = 0.050*), and are more likely to use Lorazepam (63.2%/ 37.4%, p = 0.047*), Promethazin (26.3%/ 9.6%, p = 0.044*), and (Es-)Ketamin (31.6%/ 12.8%, p = 0.039*) than representatives in group A. Both groups differ significantly in their allocation of three case scenarios to different types of PS.

Conclusions

Both definitions and patterns of clinical practice between palliative and hospice care representatives show divergence, which may be influenced one by another. A comprehensive framework considering conceptual, clinical, ethical, and legal aspects of different definitions of PS could help to better distinguish between different types and nuances of PS.
Literature
1.
Mercadante S, Intravaia G, Villari P, Ferrera P, David F, Casuccio A. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manag. 2009;37(5):771–9.CrossRef
2.
Cherny NI, Radbruch L, Board of the European Association for Palliative C. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23(7):581–93.CrossRefPubMed
3.
4.
Van Deijck RH, Krijnsen PJ, Hasselaar JG, Verhagen SC, Vissers KC, Koopmans RT. The practice of continuous palliative sedation in elderly patients: a nationwide explorative study among Dutch nursing home physicians. J Am Geriatr Soc. 2010;58(9):1671–8.CrossRefPubMed
5.
Carter MJ, Gibbins J, Senior-Smith G, Thomas S, Guest P, Forbes K. Ketamine: does it have a role in palliative sedation? J Pain Symptom Manag. 2008;36(4):e1–3.CrossRef
6.
Oosten AW, Oldenmenger WH, van Zuylen C, Schmitz PI, Bannink M, Lieverse PJ, Bromberg JE, van der Rijt CC. Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence? Eur J Cancer. 2011;47(15):2341–6.CrossRefPubMed
7.
Stiel S, Krumm N, Schroers O, Radbruch L, Elsner F. Indications and use of benzodiazepines in a palliative care unit. Schmerz. 2008;22(6):665–71.CrossRefPubMed
8.
Morita T, Akechi T, Sugawara Y, Chihara S, Uchitomi Y. Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: a nationwide survey. J Clin Oncol. 2002;20(3):758–64.CrossRefPubMed
9.
Morita T, Miyashita M, Kimura R, Adachi I, Shima Y. Emotional burden of nurses in palliative sedation therapy. Palliat Med. 2004;18(6):550–7.CrossRefPubMed
10.
Swart SJ, Brinkkemper T, Rietjens JA, Blanker MH, van Zuylen L, Ribbe M, Zuurmond WW, van der Heide A, Perez RS. Physicians’ and nurses’ experiences with continuous palliative sedation in the Netherlands. Arch Intern Med. 2010;170(14):1271–4.CrossRefPubMed
11.
Braun TC, Hagen NA, Clark T. Development of a clinical practice guideline for palliative sedation. J Palliat Med. 2003;6(3):345–50.CrossRefPubMed
12.
Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med. 2005;8(4):716–29.CrossRefPubMed
13.
Verkerk M, van Wijlick E, Legemaate J, de Graeff A. A national guideline for palliative sedation in the Netherlands. J Pain Symptom Manag. 2007;34(6):666–70.CrossRef
14.
Klosa PR, Klein C, Heckel M, Bronnhuber AC, Ostgathe C, Stiel S. The EAPC framework on palliative sedation and clinical practice--a questionnaire-based survey in Germany. Support Care Cancer. 2014;22(10):2621–8.CrossRefPubMed
15.
Stiel S, Heckel M, Christensen B, Ostgathe C, Klein C. In-service documentation tools and statements on palliative sedation in Germany--do they meet the EAPC framework recommendations? A qualitative document analysis. Support Care Cancer. 2016;24(1):459–67.CrossRefPubMed
16.
Higgins PC, Altilio T. Palliative sedation: an essential place for clinical excellence. J Soc Work End Life Palliat Care. 2007;3(4):3–30.CrossRefPubMed
17.
Hasselaar JG, Reuzel RP, Verhagen SC, de Graeff A, Vissers KC, Crul BJ. Improving prescription in palliative sedation: compliance with dutch guidelines. Arch Intern Med. 2007;167(11):1166–71.CrossRefPubMed
18.
Reuzel RP, Hasselaar GJ, Vissers KC, van der Wilt GJ, Groenewoud JM, Crul BJ. Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med. 2008;22(5):641–6.CrossRefPubMed
19.
Rietjens JA, Hauser J, van der Heide A, Emanuel L. Having a difficult time leaving: experiences and attitudes of nurses with palliative sedation. Palliat Med. 2007;21(7):643–9.CrossRefPubMed
20.
Hasselaar JG, Reuzel RP, van den Muijsenbergh ME, Koopmans RT, Leget CJ, Crul BJ, Vissers KC. Dealing with delicate issues in continuous deep sedation. Varying practices among Dutch medical specialists, general practitioners, and nursing home physicians. Arch Intern Med. 2008;168(5):537–43.CrossRefPubMed
21.
Fainsinger RL, De Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care. 2000;16(2):5–10.PubMed
22.
Douglas CD, Kerridge IH, Rainbird KJ, McPhee JR, Hancock L, Spigelman AD. The intention to hasten death: a survey of attitudes and practices of surgeons in Australia. Med J Aust. 2001;175(10):511–5.PubMed
23.
Weber M, Strohscheer I, Samonigg H, Huber C. Palliative sedation--an alternative to euthanasia in intractable pain at the end of life? Med Klin (Munich). 2005;100(5):292–8.CrossRef
24.
Alt-Epping B, Nauck F, Jaspers B. What is problematic with palliative sedation?: a review. Ethik in der Medizin. 2014;27(3):219–31.CrossRef
25.
Bozzaro C. The concept of suffering in medicine: an investigation using the example of deep palliative sedation at the end of life. Ethik in der Medizin. 2015;27(2):93–106.CrossRef
26.
Morita T, Tsuneto S, Shima Y. Proposed definitions for terminal sedation. Lancet. 2001;358(9278):335–6.CrossRefPubMed
27.
Jaspers B, Nauck F, Lindena G, Elsner F, Ostgathe C, Radbruch L. Palliative sedation in Germany: how much do we know? A prospective survey. J Palliat Med. 2012;15(6):672–80.CrossRefPubMed
28.
Hopprich A, Gunther LD, Laufenberg-Feldmann R, Reinholz U, Weber M. Palliative sedation at a university palliative care unit--a descriptive analysis. Dtsch Med Wochenschr. 2016;141(8):e60–6.CrossRefPubMed
29.
Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, Amadori D, Nanni O. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012;30(12):1378–83.CrossRefPubMed
30.
Brinkkemper T, van Norel AM, Szadek KM, Loer SA, Zuurmond WW, Perez RS. The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review. Palliat Med. 2013;27(1):54–67.CrossRefPubMed
31.
Schildmann EK, Bausewein C, Schildmann J. Palliative sedation: improvement of guidelines necessary, but not sufficient. Palliat Med. 2015;29(5):479–80.CrossRefPubMed
32.
Beel A, McClement SE, Harlos M. Palliative sedation therapy: a review of definitions and usage. Int J Palliat Nurs. 2002;8(4):190–9.CrossRefPubMed
33.
Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manag. 2002;24(4):447–53.CrossRef
34.
Alt-Epping B, Nauck F, Jaspers B. What is problematic with palliative sedation? A review. Ethik in der Medizin. 2015;27(3):2019–31.CrossRef
35.
Schildmann EK, Schildmann J, Kiesewetter I. Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines. J Pain Symptom Manag. 2015;49(4):734–46.CrossRef
36.
Alt-Epping B, Sitte T, Nauck F, Radbruch L. Sedation in palliative medicine: guidelines for the use of sedation in palliative care: European Association for Palliative Care (EAPC). Schmerz. 2010;24(4):342–54.CrossRefPubMed
Metadata
Title
Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services
Authors
Stephanie Stiel
Mareike Nurnus
Christoph Ostgathe
Carsten Klein
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2018
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-018-0303-7

Other articles of this Issue 1/2018

BMC Palliative Care 1/2018 Go to the issue

Research article

Whose job? The staffing of advance care planning support in twelve international healthcare organizations: a qualitative interview study

Research article

A public health approach to palliative care in the response to drug resistant TB: an ethnographic study in Bengaluru, India

Research article

Using co-design to develop an intervention to improve communication about the heart failure trajectory and end-of-life care

Research article

Patient’s and health care provider’s perspectives on music therapy in palliative care – an integrative review

Research article

Evaluation of the palliative symptom burden score (PSBS) in a specialised palliative care unit of a university medical centre - a longitudinal study

Research article

Quality of life in men with metastatic prostate cancer in their final years before death – a retrospective analysis of prospective data